The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.
Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...
In 2023, Moderna initiated a study on a “pandemic influenza vaccine” to protect against H5 and H7 avian influenza viruses. In July, the company received $176 million from HHS toward its ...